Certara

Certara announces the formation of a new practice area focused on healthcare

Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve worldwide equity in health. CGH is a new product development innovation practice inspired by Certara’s drug development and scientific due diligence work for the Bill & Melinda Gates Foundation.

Certara Introduces Integral data repository software

Certara has announced the introduction of Certara Integral, its data repository for collecting, managing, and storing multiple types of data sets for analysis, sharing and reporting of clinical pharmacology, pharmacometrics and other relevant clinical data.

Certara Launches Version 19.1 of its D360 scientific informatics platform

Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19.1 of its flagship scientific informatics platform D360.

D360 v19.1 expands the platform’s capabilities for biologists and biologics scientists, deepens support for small molecule chemistry, and provides workflow enhancements based on community feedback. This latest version of D360 takes its name from its calendar release date; this is the first new release in 2019.

Certara acquires Pirana

Certara has announced that it has Pirana, a product for connecting and organising pharmacometric modelling results as well as providing interfaces to a range of software tools used in pharmacometrics modelling

Certara’s launches D360 Version 10.5

Certara, a provider of model-informed drug development, has announced the launch of D360 v10.5, the first in a series of releases focused on delivering biologic-relevant tools together with D360’s world-class data access capabilities

Pages

Subscribe to RSS - Certara